Clinical trial
Human Papillomavirus-Associated Cervical Neoplasia in Switzerland at the Start of a National Vaccination Programme: Crosssectional Study
NCT02323997 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Papillomavirus-Associated Cervical Neoplasia in Switzerland at the Start of a National Vaccination Programme: Crosssectional Study
- Lead sponsor
- University of Bern
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- May 31, 2016
- Enrollment
- 767 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer